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Heart disease is the leading cause of global mortality, accounting for 13.7 million deaths annually. 
Optimising depression and anxiety symptoms in adults with heart disease is an international priority. Heart 
disease secondary prevention is best achieved through implementation of sustainable pharmacological 
and non-pharmacological interventions, including meditation. Meditation is a means of generating self-
awareness and has implications for enhanced self-management of depression and anxiety symptoms. This 
review aims to identify high-level quantitative evidence for meditation interventions designed to improve 
depression and/or anxiety symptoms among adults with heart disease and ascertain the most important 
elements of meditation interventions that facilitate positive depression and/or anxiety outcomes. This 
systematic review and narrative synthesis was completed in accordance with the PRISMA Statement and 
has adhered to the Cochrane Risk of Bias guideline. Six databases were searched between 1975 and 
2017. Statistically significant outcomes were demonstrated in over half (5/9) of the phase II meditation 
studies for depression and/or anxiety and involved 477 participants. Meditation interventions that 
generated positive outcomes for depression and/or anxiety included elements such as focused attention to 
body parts (or body scan) (3/4 studies) and/or group meetings (4/5 studies). Meditation is a means of 
reframing heart disease outpatient services towards an integrated model of care. Future adequately 
powered phase III studies are needed to confirm which meditation elements are associated with reductions 
in depression and anxiety; and the differential effects between concentrative and mindfulness-based 






 Heart disease is the leading cause of death in both developed and developing countries (World 
Health Organisation, 2014; World Health Organization, 2014). Evidence targeting sustainable non-
pharmacological interventions to optimise modifiable heart disease risk factors is an international priority 
(Mendis et al., 2005). The American Heart Association recommends the use of meditation as an adjunct to 
guideline-directed cardiovascular risk reduction (Levine et al., 2017). Calls for further research for 
meditation’s effectiveness in large phase III trials are required to facilitate the implementation of mediation 
into heart disease clinical settings (Brook et al., 2013; Levine et al., 2017).  
Depression is an independent risk factor for further cardiac events (Grippo & Johnson, 2002), 
whereas comorbid depression and anxiety are significantly associated with increased heart disease 
morbidity and mortality (Grippo & Johnson, 2002; Szekely et al., 2007). After an acute cardiac event or 
hospitalisation, rates of depression and anxiety are high, which persists on entry into cardiac rehabilitation 
programs (Milani & Lavie, 2007). It is essential that clinicians identify and work with patients post an acute 
cardiac event to ensure that those who have depression or anxiety are able to improve their chances of 
both mental and physical recovery. Specific psychological stressors for cardiac patients generally occur 
between the first few weeks after an acute cardiac hospitalisation up to six months post discharge. These 
can be in varied forms, such as existential anxiety, characterised by lingering fears of recurrence or 
progression of the disease, uncertainty and vulnerability (Simony, Pedersen, Dreyer, & Birkelund, 2015), 
high incidence of post-coronary bypass depression (Tully et al. 2012), as well as adjustment to reductions 
in physical function and quality of life (Fredericks, Lapum, & Lo, 2012). Whilst there are recommended 
pathways for referral of cardiac patients with depression and anxiety, depressive symptoms are often 
mistaken as cardiac in nature, and optimal treatment for these patients is often overlooked during the 
inpatient phase (Ceccarini, Manzoni, & Castelnuovo, 2014). How adults with heart disease can be best 
supported in this period of their heart disease trajectory is seldom explored outside an exercise based 
program (Taylor et al., 2014), leaving avenues for mind-body therapies such as meditation to address the 
unmet psychological support needs of these patients. 
Meditation is a means of generating self-awareness and acceptance, which can facilitate adaptive 
affective regulation, behaviour change, and alleviation of depression and anxiety symptoms (Goyal et al., 
2014). Skills attained through meditation such as grounding and centering provide opportunities for 




interventions, thereby optimising self-management. Meditation may also lead to earlier detection of stress-
ruminative thoughts and physiological arousal, enabling opportunities to engage in more effective coping 
responses (Toneatto & Nguyen, 2007). Whilst the predominant focus of secondary prevention has been 
towards the modification of physiological risk, meditation can empower individuals by identifying the role 
they play in addressing the emotional component of their illness (Schlitz, Amorok, & Micozzi, 2005). 
 Meditation can be defined as “…practices that self-regulate the body and mind, thereby affecting 
mental events by engaging a specific attentional set” (Cahn & Polich, 2006, p. 180). Meditation is 
commonly classified into two types, concentrative and mindfulness meditation. Concentrative meditation 
types, such as Transcendental Meditation, Benson’s Relaxation Response or guided imagery, involve a 
focus on a specific mental or sensory activity, such as a repeated sound, visualised image(s) or specific 
body sensations such as breath (Cahn & Polich, 2006). Mindfulness encourages a present-moment 
awareness of thoughts, feelings, and sensations without attachment or analysis of mental contents (Cahn 
& Polich, 2006). There is overlap between the two approaches, as concentrative practices incorporate 
mindfulness by allowing thoughts to pass without attachment, returning attention to the object of 
concentrative awareness, whilst mindfulness encourages a return to an open, non-judgemental attentive 
set (Cahn & Polich, 2006). Whilst methods used to elicit state changes differ across practices, both 
approaches can mutually influence and enhance each other, producing similar changes towards an 
expanded awareness or consciousness (Cahn & Polich, 2006; Lutz, Slagter, Dunne, & Davidson, 2008). 
Meditation and deep breathing are the two most commonly utilised mind-body therapies in cardiac 
rehabilitation programs for psychological and emotional well-being (Grant, Bin, Kiat, & Chang, 2012). 
Mindfulness meditation has demonstrated effectiveness in meta-analytic reviews in reducing risk for 
relapse in successfully treated depressed patients (Toneatto & Nguyen, 2007), and for coping with distress 
and disability across a broad range of chronic illnesses (Grossman, Niemann, Schmidt, & Walach, 2004), 
thereby supporting its use as an adjunct secondary prevention strategy. Meditation has also demonstrated 
capacity to improve a range of health outcomes in heart disease populations during hospitalisation and in 
the post-operative period, and there is strong evidence supporting the integration of mind-body therapies 
generally into cardiac rehabilitation programs (Astin, Shapiro, Eisenberg, & Forys, 2003; Casey et al., 
2009; Chang, Casey, Dusek, & Benson, 2010; Hui, Wan, Chan, & Yung, 2006). However, the potential for 
meditation to be implemented in the outpatient cardiac rehabilitation setting, at a time when these adults 




strategies to reduce depression and anxiety in heart disease populations is particularly important at this 
time point, as it occurs in the context of the patients psychosocial and socioeconomic circumstances; and 
is conducted in a setting that is supported by conventional medicine, which is likely to encourage 
participants and improve adherence (Linden, 2000) to meditation as an adjunct cardiac risk reduction 
strategy. This systematic review aims to: 1) identify high levels of evidence for adjunct meditation 
strategies designed to improve depression and anxiety symptoms among adults with heart disease, and 2) 
classify the elements of meditation interventions that facilitate improvements in depression or anxiety after 
a cardiac event. 
METHOD 
Study design  
 A systematic review of RCT and quasi-experimental studies conducted in accordance with the 
PRISMA Statement.  
Eligibility criteria 
 The populations included in this review were adults with modifiable risk factors for heart disease, 
coronary heart disease, valvular disease, or heart failure (hypertension, angina, atrial fibrillation, or 
breathlessness), and/or have undergone a surgical procedure (cardiac bypass surgery-coronary, aortic or 
valvular; pacemaker or defibrillator insertion or pericardial window) and/or an interventional procedure 
(coronary angiogram, percutaneous coronary intervention, ablation or other procedure); who participated in 
a clinic or outpatient disease management program after a recent inpatient hospitalisation. Interventions 
included meditation techniques that fit the operational definition, as previously described (refer page 3). 
Guided imagery has been included as it is an inherent component of some meditation practices that 
incorporate aspects of spirituality (Delaney & Barrere, 2008), and is in alignment with the goals of some 
meditation practices to achieve heightened awareness (Cahn & Polich, 2006; Tusek, Cwynar, & Cosgrove, 
1999). Comparison groups were identified as conventional cardiac rehabilitation programs offered in 
mainstream outpatient healthcare settings or clinic-based programs or interventions. Outcomes considered 
were depression and/or anxiety.  
Exclusion criteria were interventions involving yoga, qigong, predominately exercise-based 
interventions and/or multicomponent interventions that did not discretely analyse the meditation 
component; relaxation interventions that did not include a meditation component (such as biofeedback, 




rehearsal practices (for example, for peak performance) were excluded as they are a relaxation practice 
that is independent of meditation. Non-English articles and abstracts were excluded. 
Information sources 
 This systematic review was completed in accordance with the PRISMA Statement. Databases 
searched included MEDLINE, AMED, CINAHL, Embase, PsycInfo and the Cochrane Database of 
Systematic Reviews between 1975 and 27th September 2017. Reference lists were also searched for 
additional articles. 
Search Strategy  
 The keywords and search terms used in MEDLINE and CINAHL (Refer Supplementary Appendix 
S1).  
Study Selection and data collection process 
 Titles and abstracts were screened for eligibility and all duplicates were removed (AR). 
Uncertainties around articles for inclusion were resolved by consensus (AR, LH & PN). The full-text article 
related to one abstract was obtained. Significant heterogeneity between intervention content, designs and 
outcomes precluded the use of meta-analysis and results were synthesised in a narrative review. To 
classify the elements of included interventions, each line of text describing the interventions were coded by 
one investigator (AR). Each element was listed in a table until all were included. Common elements were 
then identified and tallied across interventions. 
Risk of Bias 
 A Cochrane Risk of Bias Table was used to report the risk of bias within and across studies 
(Higgins et al., 2011). 
RESULTS 
Study Selection 
 The initial search generated 780 articles, which after a process of review, elimination and hand 
searching, were reduced to nine articles for inclusion (Refer Figure 1). 
Insert figure 1 here 
Study Characteristics 
 Of these nine studies, four studies were phase II RCTs and five studies were pre and post-test 
designs. The majority of the 9 included studies were conducted in high-income countries (n=7) including 




(n=1) and Iran (n=1), which are considered low-income countries. The mean number of participants was 53 
(SD ± 33), with a mean age of 60 years (SD ± 6). Just over two-thirds of the participants were male (67%), 
with one study including only men (Parswani, Sharma, & Iyengar, 2013). 
 Concentrative meditation types were used in four studies, including guided imagery (Collins & 
Rice, 1997; Luskin, Reitz, Newell, Quinn, & Haskell, 2002; Mandel, 2007) and Transcendental Meditation 
(Paul-Labrador et al., 2006). Mindfulness-Based Stress Reduction or Mindfulness meditation were used in 
five studies (Delaney, Barrere, & Helming, 2011; Delui, Yari, Khouyinezhad, Amini, & Bayazi, 2013; 
Nyklíček, Dijksman, Lenders, Fonteijn, & Koolen, 2014; Parswani et al., 2013; Salmoirago-Blotcher et al., 
2013), with one of these studies categorising participants into mindfulness only or combined mindfulness 
and concentrative meditation techniques according to Spirituality Scale scores (Delaney et al., 2011). The 
mean frequency of group meditation interventions was 11 sessions (SD ± 7; n = 5 studies), and the mean 
duration of these sessions was 68 minutes (SD ± 27; n = 5 studies). Four studies did not utilise group 
meditation practices. The average amount of personal instruction received across studies was 3 sessions 
(SD ± 3; n = 5 studies), with a mean duration of 45 minutes (SD ± 27; n = 4 studies). Home practice was 
utilised at an average of 1.3 sessions (SD ± 0.8; n = 9 studies); with a mean duration of 23 minutes (SD ± 
9; n = 6 studies). The mean intervention period across studies was 9.5 weeks (SD ± 4.8; n = 8 studies). In 
one study the intervention period was unclear (Delui et al., 2013) (refer Table 1). Time since the patients’ 
cardiac event ranged between 1 week and 12 months. Individual data around time since admission or 
cardiac event was not reported in any of the included studies.   
Setting 
Interventions took place across a number of settings, including a university medical centre (tertiary 
care) (Salmoirago-Blotcher et al., 2013), an outpatient clinic (Parswani et al., 2013), or in an outpatient 
cardiac rehabilitation centre (Collins & Rice, 1997; Delaney et al., 2011; Delui et al., 2013; Mandel, 2007). 
The setting was not clearly defined in three studies (Luskin et al., 2002; Nyklíček et al., 2014; Paul-
Labrador et al., 2006). 
Intervention delivery 
 A variety of methods were used for intervention delivery that included an intial session delivered by 
the researcher (Paul-Labrador et al., 2006), followed by self administered home practice with an audiotape 
or CD (Delaney et al., 2011; Paul-Labrador et al., 2006; Salmoirago-Blotcher et al., 2013); investigator 




(Paul-Labrador et al., 2006), phone delivery of sessions by health care professionals and graduates of a 
mindfulness training program (Salmoirago-Blotcher et al., 2013); use of a certified clinical psychologist with 
10 years expereince in mindfulness/vipassana meditation and 5 years supervision experience (Nyklíček et 
al., 2014); a licensed psychotherapist (Luskin et al., 2002); a music therapist trained and supervised by the 
study investigator, who has extensive experience eliciting the relaxation response (Mandel, 2007); or was 
not specified (Delui et al., 2013; Parswani et al., 2013). 
Control and/or Comparison Groups 
 Usual care was clearly defined in seven of the nine studies. Usual care was described as a 
conventional cardiac rehabilitation program in one study that included exercise and peer support (Collins & 
Rice, 1997), or was not specified (Delui et al., 2013). Usual care also included one month follow-up with a 
cardiologist (Parswani et al., 2013). In one study, a waitlist control was used where participants were 
offered relaxation or meditation training at the end of the study (Luskin et al., 2002). Comparison groups 
included a 10 minute phone call regarding defibrillator concerns (Salmoirago-Blotcher et al., 2013); a self-
help booklet based on group psycho-education sessions (Nyklíček et al., 2014), maintenance of a regular 
diet as suggested by the medical team, 30 minutes of regular exercise, and a single (Parswani et al., 
2013), or weekly health education class for heart disease risk factor modification (Paul-Labrador et al., 
2006). Two studies did not include a control or comparison group (Delaney et al., 2011; Mandel, 2007). 
Insert Table 1 here 
Risk of Bias Assessment 
 All nine meditation studies have an inherently high risk of bias due to the inability to blind study 
participants and intervention delivery personnel (n=9). Apart from this unavoidable risk other identified 
reasons for bias included incomplete or no randomisation in quasi-experimental designs (n= 3) (Delaney et 
al., 2011; Luskin et al., 2002; Mandel, 2007); lack of allocation concealment procedures (n=3) (Delaney et 
al., 2011; Luskin et al., 2002; Mandel, 2007); blinding of outcome assessors for patient reported outcomes 
(n= 3) (Collins & Rice, 1997; Delaney et al., 2011; Mandel, 2007); and/or incomplete outcome data for 
measures taken at greater than 6 weeks (n= 3) (Mandel, 2007; Parswani et al., 2013; Paul-Labrador et al., 
2006) (refer Table 2).  





 Whilst none of these studies were adequately powered, significant improvements in depression 
and/or anxiety were demonstrated over half (5/9) of the identified phase II meditation studies. Populations 
with significant improvements in depression and/or anxiety included adults with congestive heart failure 
(n=33), coronary heart disease or cardiovascular disease (n=85), metabolic syndrome with comorbid CHD 
(n= 103), CVD with comorbid depression (n=45), recipients of a percutaneous coronary intervention (n= 
114), or male recipients of an automatic implantable cardioverter defibrillator (AICD) (n= 52). Significant 
interventions included guided imagery (2 studies), Mindfulness-Based Stress Reduction (2 studies), or 
Mindfulness meditation (1 study) (refer Table 1). 
Depression 
Four studies demonstrated statistically significant between-group differences in depression. A 
further three studies did not show improvements in depression after using meditation, and two studies did 
not assess depression outcomes. Three of the studies that generated significant between-group 
differences in depression utilised a mindfulness meditation approach such as MBSR (Delui et al., 2013; 
Parswani et al., 2013), or an adapted version of MBSR (Nyklíček et al., 2014), whilst one other successful 
study used concentrative meditation techniques, including guided imagery (Luskin et al., 2002). 
Anxiety  
 The results for state anxiety were equivocal. One out of two studies evaluating meditation’s 
effectiveness for state anxiety generated statistically significant within-group differences using guided 
imagery (Mandel, 2007). None of the two studies that utilised concentrative meditation approaches such as 
guided imagery (Mandel, 2007) or Transcendental Meditation (Paul-Labrador et al., 2006) were successful 
in demonstrating improvements within or between groups in trait anxiety. Two studies that generated 
statistically significant improvements in overall anxiety between groups both used either MBSR (Parswani 
et al., 2013) or an adapted version of MBSR (Nyklíček et al., 2014). However, a further five studies that 
utilised either an adapted version of MBSR (Salmoirago-Blotcher et al., 2013), mindfulness (Delaney et al., 
2011; Delui et al., 2013) or guided imagery (Collins & Rice, 1997; Luskin et al., 2002) did not demonstrate 
improvements in overall anxiety within or between groups. 
Elements of meditation interventions 
 The elements of meditation interventions that facilitate improvements in depression and/or anxiety 
outcomes are highlighted in Supplementary Appendix S2. All included studies advised participants to 




parts or a ‘body scan’ generated significant results in depression, anxiety (Nyklíček et al., 2014; Parswani 
et al., 2013) and state anxiety (Mandel, 2007). However, one of these studies did not produce significant 
results for trait anxiety (Mandel, 2007). Four out of five studies that utilised group meetings demonstrated 
statistically significant improvements in depression (Delui et al., 2013; Luskin et al., 2002; Nyklíček et al., 
2014; Parswani et al., 2013) and/or anxiety (Nyklíček et al., 2014; Parswani et al., 2013). However, two of 
these studies did not generate significant improvements in anxiety (Delui et al., 2013; Luskin et al., 2002). 
Mindfulness as a potential mediator of meditation efficacy for depression and anxiety symptoms 
 Interestingly, two studies that used adapted mindfulness meditation also generated statistically 
significant improvements in mindfulness (Nyklíček et al., 2014; Salmoirago-Blotcher et al., 2013). In one of 
these two studies, increases in mindfulness were found to mediate the improvements in depression in 
anxiety symptoms between the intervention and comparison group in adults <60 years (Nyklíček et al., 
2014). 
DISCUSSION 
 There were no phase III randomised controlled trials to determine the effectiveness of meditation 
for the secondary prevention of depression and anxiety for adults who have recently experienced a cardiac 
event or hospitalisation. Based on the results of this review, there is evidence to suggest that meditation 
can improve depression and anxiety in patients with heart disease. Whilst there is no definitive evidence, 
common elements of effective meditation interventions that may influence depression and/or anxiety 
outcomes include: focused attention to body parts or ‘body scan’, and group meetings (particularly with 
depressed patients).  
 This review identified that 67% of participants were male, and there were no meditation studies 
specifically designed for women. These results are consistent with the AHA consensus statement, 
reflecting the underrepresentation of women with heart disease in clinical trials and reduced referral rates 
to outpatient secondary prevention programs (Mehta et al., 2016). This is significant given that women 
have higher rates of heart disease morbidity and mortality compared to men (Benjamin et al., 2017) and 
experience poorer outcomes after a cardiac event (Udell et al., 2017). Collaborative group-based 
approaches such as meditation may also address the unique psychosocial support needs of women 
alongside conventional exercise-based programs (Davidson et al., 2008). 
 Findings of this review are consistent with previous systematic reviews of meditation that have 
demonstrated small, consistent improvements in anxiety, stress and depression in clinical (Goyal et al., 




quality of life in heart failure patients (Kwekkeboom & Bratzke, 2015). However, it is difficult to determine 
meditation efficacy given an unknown dose-response relationship, mechanism of effect and significant 
heterogeneity within and between study designs (Delaney et al., 2011). Measures of self-efficacy have also 
been recommended to determine the degree to which participants can adapt and integrate new relaxation 
strategies into their lifestyle and identify areas where further training is required (Gordon, 2007).   
One study found mindfulness to be a mechanism of change, which could indicate that mindfulness 
practices positively affect anxiety by improving cognitive flexibility (Lee & Orsillo, 2014). Focusing on the 
breath, an element common to a variety of meditation practices, involves aspects of cognitive flexibility 
such as maintaining attention to the breath, inhibiting focus to other thoughts when the mind wanders and 
switching attention back to the breath (Lee & Orsillo, 2014). Thus, focusing on the breath and the ‘body 
scan’, which again draws attention to the sensation of different body parts, is likely to assist in the 
development of practices that enhance cognitive flexibility and are challenging skills for adults with 
generalised anxiety disorder to develop (Lee & Orsillo, 2014).  
 Risk of bias in meditation studies is frequently high given the inability to blind the participant or 
practitioner (Astin et al., 2003). There will always be an element of provider-participant interaction that 
contributes to a risk of bias, however, this should not overshadow positive findings of robust study designs 
and the potential for translation of findings into practice. One way around bias appraisal has been to 
implement a modified Jadad scale with a maximum score of 4 rather than 5, with no points assigned to 
information provided with regards to participant blinding (Canter & Ernst, 2004). Controlled trial designs 
may require minimising therapeutic interaction between participant and provider to accurately assess 
meditation efficacy, however, this may reduce ecological validity and thereby reduce the potential 
treatment effect (Mandel, 2007). Various factors, such as levels of anxiety, depression, stress, recent life 
events and personality (Fava & Sonino, 2010), may also determine which elements of meditation (for 
example guided imagery vs mindfulness) might be most suitable in initiating meditation practice, which 
requires exploration in future qualitative or mixed methods designs. 
 A few studies have explored the effect of age as a covariate for meditation effects. One study 
determined that younger patients (<60 years) benefited most from meditation (Nyklíček et al., 2014). Such 
differences in outcome measures could be a floor effect, that is, older adults with CVD are more likely to 
report higher baseline quality of life compared to younger adults, and lower levels of psychological distress 




secondary prevention strategy given increased openness to complementary therapies and higher baseline 
levels of psychological distress (Gordon, 2007; Lavie & Milani, 2006; Rabito & Kaye, 2013). 
 A floor effect was also identified in one study as a reason for non-significant within-group changes 
in depression post-intervention (Delaney et al., 2011). Baseline state anxiety in two studies (Collins & Rice, 
1997; Delaney et al., 2011) was also lower than the suggested 39-40 STAI-S cut-off score for clinically 
significant symptoms (Julian, 2011). Baseline mean scores in two other non-significant studies indicated 
mild trait anxiety on the STAI-T (Paul-Labrador et al., 2006), and less than clinically significant anxiety on 
the HADS (Bunevicius et al., 2013; Salmoirago-Blotcher et al., 2013) which may have contributed to non-
significant results in these studies. The capacity of meditation interventions to capture changes in trait 
anxiety using the STAI may be limited given that the purpose of the trait subscale is to determine anxiety 
as a longstanding characteristic, and is less responsive to change (Julian, 2011). Meditation interventions 
delivered over longer periods of time, with longer follow-up periods may be required to capture changes in 
trait anxiety, such as heightened sensory awareness and shifts in the relationship between thoughts, 
feelings, and sense of self that are often seen in experienced meditators (Cahn & Polich, 2006). 
Implications for practice 
 Utilising a novel approach such as meditation addresses a clearly identified need to reframe 
cardiac rehabilitation service provision from a conventional prescriptive approach to an integrated disease 
management model (Davidson, 2015). Small group meditation instruction also provides an opportunity for 
peer support and trust building, provides a safe environment for relaxation and promotes positive 
interaction between care provider and participant, which is vital to maintain health behaviour change 
(Clark, Whelan, Barbour, & MacIntyre, 2005).  
 Meditation also has the potential to reduce health care utilisation and costs (Rutledge et al., 1999), 
however formal cost-benefit analyses are required for confirmation, and to ensure effective resource 
utilisation (Krisanaprakornkit, Krisanaprakornkit, Piyavhatkul, & Laopaiboon, 2006). It is also important to 
consider patient preferences and determine the specific demographic and clinical characteristics of cardiac 
rehabilitation participants that are most likely to adhere to and benefit from a meditation intervention. 
Implications for research 
 Future well designed, methodologically rigorous studies with sufficient detail around intervention 
content and setting are required to allow for replication, and reporting of these studies should adhere to the 




reporting of meditation intervention elements to better identify which elements are most effective in 
reducing cardiovascular risk (Hickman et al., 2015). The inclusion of data such as time since admission or 
cardiac event and stratification of depression and anxiety rates by gender and type of cardiac procedure is 
required in the reporting of future studies to shed light on which cardiac populations would most benefit 
from a meditation intervention. Gender differences in receptivity to meditation and its effectiveness also 
needs to be considered in future research. Multicomponent interventions need to discretely analyse the 
meditation component of their intervention. Research designs targeted to patients with a minimum of mild 
depression or anxiety symptoms may lead to better outcomes attributable to meditation interventions. 
Strategies to control for secondary relaxation effects associated with meditation and practitioner interaction 
effects (Lee & Orsillo, 2014), such as a relaxation comparison group, are required in future phase III 
meditation intervention designs. 
Limitations 
 This review is limited by the small number of methodologically strong studies, and lack of 
availability of any phase III RCT’s that were solely evaluating meditation effects. Some of the included 
meditation intervention descriptions were brief, limiting conclusions drawn around the optimal elements of 
meditation interventions that may improve outcomes, as well as replication and generalisability of the 
findings. The authors acknowledge the potential for confounding factors to affect the results of individual 
studies included in the review. 
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Table 1: Summary Table of Meditation Interventions 











IP Before mean (SD): After mean (SD), or 
differences between 






























mental procedure; sitting 
comfortably with eyes closed. 
Calming of ordinary thinking 
processes, towards a 
psychophysiological state of 
restful alertness (Schneider et 
al., 2001). Introductory lecture, 
personal interview, group 






F: 2x daily 
HP; 2 x IL; 
PI x 1; Pin 
x 1; 3 x 
GM; then 






D: HP not 






CES-D IG: 6.8 (7.1) 
CES-D CG: 12.2 
(10.7) 
STAI (T): IG: 14.4 
(10.1) 
STAI (T): CG: 17.8 
(11.7) 
CES-D: IG 7.1  (6.9)  
CES-D: CG: 11.2 
(10.0) 
STAI (T): IG: 12.8 
(7.9) 




depression (p= 0.053) 
or trait anxiety (p= 
0.31) between groups 


























Adapted Mindfulness based 
stress reduction: 1) body 
scan –attention to bodily 
sensations and cognitions; 2) 
training in breathing 
awareness. sitting 
meditation with mindful 
eating, drinking, attention to 
sounds, visual objects, 
thoughts & emotions); daily 



















HADS IG: 5.5 (4.1) 
HADS CG: 6.4 (4.1) 
HADS: beta=-1.15 
(95% CI: 0.046, -
2.344) 
No significant 
reduction in anxiety 
between groups 




















Mindfulness based stress 
reduction (body scan, 
sitting meditation, mindful 















HADS A IG: 3.27 
(1.27) 
HADS A CG: 7.53 
(3.33) 






India breathing space –resting 
awareness of inner 
experience, focus and 













HADS D IG: 
6.13(2.03) 
HADS D CG: 
4.93(2.49) 
 
HADS D IG: 3.33 
(1.59) 

























Adapted Mindfulness Based 
Stress Reduction, 
(mindfulness of bodily 
sensations, emotions and 
thoughts in an upright position, 
discussion of experiences 
during home practice), 
psycho-education (role of 
behaviour, bodily sensations, 
emotions, thoughts in 





















SAD-4: IG: 2.42 
(0.41) 




t (102)= 3.46 
Improved depression 
and anxiety between 
groups at 6 weeks 
(p<0.01); 
Younger adults more 
likely to have greater 
decreases in anxiety/ 






judgemental acceptance of 
























Progressive muscle relaxation 
and guided imagery (mental 
journey to a pleasant relaxing 
setting using the senses; think 
of the heart as healed and 

























STAI (S) IG: 33.50 
(8.41)  






STAI (S) IG: 32.05 
(9.34) 
STAI (S) CG: 31.48 
(8.59) 
Between groups/ time: 




reduction in state 
anxiety (p>0.05), or 
anxiety between 






















Guided imagery (conscious 
shifting of attention from 
stressful experiences to an 












GDS IG: 8.3 (6.0) 
GDS CG: 5.3 (6.3) 
STAI IG: 40.2 (8.0) 
STAI CG: 36.4 (9.9) 
GDS IG: 5.5 (3.0) 
GDS CG:  6.0 (6.8) 
STAI: IG: 35.9 (7.1) 
STAI: CG:36.6 (11.1) 
Reduced depression 
between groups at 10 
weeks (p=0.02). No 






visualisation of positive 
emotion or memory, holding of 
that feeling/emotion within the 
heart; stress education 
(discussion of secondary gain, 
practice of deep breathing, 
pausing before making a 
decision, review of stress 
management research 




daily HP x 
























15 Deep breathing, guided 
imagery (comfortable place), 
visualisation for muscle 
relaxation, comforting word or 
phrase, positive affirmations  










STAI (S): 44.14 
(14.35)  
STAI (T): 40.27 
(11.79) 




STAI (S): 35.36 
(12.06) 
2 weeks: 
CES-D: 15.5 (12.31) 
STAI (T): 35.75 
(11.95) 
4 months: 
CES-D: 11.0 (10.42) 
STAI (T): 34.00 (9.97) 
Within group 
differences: 
Improved state anxiety 
post Pin (p=0.002). No 
significant reductions 
in depression 
(p=0.67/0.07) or trait 
anxiety (p=0.31/0.44) 





al. (2011)  
 
US 










41 Mindfulness meditation, 
present moment awareness, 
setting aside worrisome 
thoughts, attention to 
breathing, guided 
visualisation of a small circle 
of light from the head to the 
heart and chest area, recall a 
situation of feeling loved or 
loving, connecting to a higher 
power, sending and receiving 
of loving energy, 
prayer/reflection in a 
perceived healing 
environment  
n/a F: Pin x 












CES-D: 19.49 (5.3) 
STAI (S): 24.03 (2.4) 
CES-D: 18.75 (4.2) 






or anxiety (p=0.19) 




























(details not stated);  routine 
CR. 
Jacobsen’s 









BDI IG: 21.93±7.226 
BDI: PMR: 
21.60±7.491 
BDI IG v PMR: 7.60 
(1.64) 
BDI IG v CG: 5.73 
(1.64) 
Significantly reduced 
depression v PMR 





























Zung IG v PMR: 3.07 
(1.95) 





reductions in anxiety 
vs PMR (p=0.27) or 
CG (0.25) post 
intervention 
Key: P, Population; SD, Standard Deviation; *, Where reported; M, Male; F, Female; O, Outcome; N, Number; IP, Intervention period; US, United States;  
RCT, Randomised controlled trial; CHD, Coronary Heart Disease; D, Depression, TA, Trait Anxiety; CES-D, Centre for Epidemiological Studies Depression 
Scale; STAI, State Trait Anxiety Inventory; IG, Intervention Group; CG, Control Group; F, Frequency; HP, Home Practice; IL, Introductory Lecture; PI, 
Personal instruction; Pin, Personal interview; GM, Group Meeting; D, Duration; min, Minutes; STAI (T), Trait anxiety; ICD, Implantable Cardioverter 
Defibrillator; A, Anxiety; HADS, Hospital Anxiety and Depression Scale; v, Versus, HADS A, Hospital Anxiety and Depression Scale Anxiety Subscale; HADS-
D, Hospital Anxiety and Depression Scale Depression Subscale;  PCI, Percutaneous Coronary Intervention; SAD-4, Symptom Anxiety Depression Index- 4; 
CR, Cardiac Rehabilitation; CVD, Cardiovascular Disease, MI, Myocardial infarction, CABG, Coronary artery bypass graft; STAI (S), State anxiety; n/s, not 




Table 2: Assessment of Risk of Bias 
Author/Ye
ar 











Blinding of outcome 

































Individually instructed by 
investigator during initial 
study visit. 
n/a Low risk 
5% IG; 4% CG 















n/a Low risk 
12% overall 
attrition 


























collected and analysed 
by personnel blinded to 
treatment status” 
n/a n/a High risk 
18% overall 
attrition 













No binding used 
High risk 
No blinding used. 
Author did not interact 
with patients during the 
intervention. 















No blinding used 
High risk 
No blinding used 





































No blinding used 
Low risk 






























No information provided 











for study personnel 
33% CG at 3 

















Unclear if rehabilitation 
nurses BP blinded to 
group assignment. 
‘Post-test measures 
conducted by individual 
blinded to treatment 
condition’. 





out not specified 









High risk;  




for study personnel 
Unclear risk 
No information provided 
n/a Low risk 
<20% attrition 
12% IG; 14% CG 
Missing data 
imputed 
n/a Low risk 
Total 4 low risk 
2 unclear risk 
3 high risk 
1 low risk 
5 unclear risk 
3 high risk 
9 high  risk 
 
3 low risk 
3 unclear risk 
3 high risk 
9 n/a 4 low risk 
1 unclear risk 
4 n/a 
3 high risk 
1 low 
5 n/a 
9 low risk 

































Records after duplicates removed 
(n = 727) 
Records screened 
(n = 727) 
Records identified through 
database searching. 
(n = EMBASE/MEDLINE (540); 
CINAHL/ PSYCINFO (65), AMED 
(20), Cochrane (144) = 769 
Records excluded 
(n = 649) 
Additional records identified 
through other sources 
(n =11) 
Full-text articles assessed 
for eligibility 
(n =78) 
Full-text articles excluded, with 
reasons 
(n = 69) 
 
Adolescents/ children =3 
Inpatients=12 
No depression/anxiety outcomes 
n= 2 
Commentary/ foreward =3 
Biofeedback, autogenic training, 
PMR/breathing exercises =10 
Multicomponent =2 
Healthy adults = 3 
No recent cardiac admission/event 
or CR = 14 
Review = 5 
Not experimental = 3 
Includes exercise component (e.g. 
yoga, tai chi, Qigong) = 8 
Report = 1 
Editorial = 1 
Design/methods paper =1 
Non-English = 1 
 
Studies included in 
quantitative synthesis 
(n = 9) 
